Literature DB >> 10599831

Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains.

O Zachrisson1, J de Belleroche, K R Wendt, S Hirsch, N Lindefors.   

Abstract

In the light of earlier findings of reduced cholecystokinin (CCK) peptide and CCK mRNA levels in the cerebral cortex, we have used in situ hybridization to examine possible regulation of mRNAs coding for two isoforms of the CCK(B) receptor in frontal cortex (Brodmann's area 10) of schizophrenic patients. The hybridizations revealed a 51% decrease of the full length CCK(B) receptor mRNA in the outer layers (II-III) of the frontal cortex. The corresponding alterations for the truncated isoform were a 65% reduction in the outer layers and a 62% reduction in the inner layers (IV-VI) of the frontal cortex. This strengthens the hypothesis that CCKergic transmission in this part of the brain is involved in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599831     DOI: 10.1097/00001756-199911080-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 3.  Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.

Authors:  David Pritchett; Katharina Wulff; Peter L Oliver; David M Bannerman; Kay E Davies; Paul J Harrison; Stuart N Peirson; Russell G Foster
Journal:  J Neural Transm (Vienna)       Date:  2012-05-10       Impact factor: 3.575

4.  Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia.

Authors:  Brian Dean; Madhara Udawela; Elizabeth Scarr
Journal:  BMC Psychiatry       Date:  2016-05-20       Impact factor: 3.630

Review 5.  Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.

Authors:  Santiago J Ballaz; Michel Bourin
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.